You are here: All Products  > Transcenta Starts US Arm of US-China Bi-specific PD-1 Trial for Solid Tumors

Transcenta Starts US Arm of US-China Bi-specific PD-1 Trial for Solid Tumors

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products